Your account is not claimed yet. You can sign up with ORCID to claim your account.

Anne W Beaven (Anne Beaven)

Years Active: 2018-2021
Publications (10 Years): 5

University of North Carolina at Chapel Hill School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of North Carolina at Chapel Hill School of Medicine

United States

Director Lymphoma Program; Associate Professor :: Medicine: Hematology/Oncology

Publications

Moriah Forster, Timothy P Moran, Anne W Beaven, Timothy J Voorhees
Novel ZAP-70-Related Immunodeficiency Presenting with Epstein-Barr Virus Lymphoproliferative Disorder and Hemophagocytic Lymphohistiocytosis. Case reports in immunology 2021 (2021)
Prioty Islam, David Rizzieri, Chenyu Lin, Carlos de Castro, Louis Diehl, Zhiguo Li, Joseph Moore, Tod Morris, Anne W Beaven
Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Cancer investigation 39 (10) (2021)
Timothy J Voorhees, Kavya K Kannan, Jonathan Galeotti, Natalie Sophia Grover, Rakhee Vaidya, Dominic T Moore, Nathan D Montgomery, Anne W Beaven, Christopher Dittus
Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantation. Leukemia & lymphoma 62 (1) (2020)
Tyler Walburn, Natalie Sophia Grover, Colette J Shen, Raghuveer Ranganathan, Christopher Dittus, Anne W Beaven, Andrew Z Wang, Kyle Wang
Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphoma. Leukemia & lymphoma 62 (1) (2020)
Kathryn E Hudson, David Rizzieri, Samantha M Thomas, Thomas W LeBlanc, Zachary Powell, Louis Diehl, Joseph O Moore, Carlos DeCastro, Anne W Beaven
Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study. British journal of haematology 184 (4) (2018)

Anne W Beaven.css-eqlu8i{font-size:small;padding-left:4px;} (Anne Beaven)